Summit Therapeutics Inc (SMMT)
19.99
+0.03
(+0.15%)
USD |
NASDAQ |
Nov 05, 14:36
Summit Therapeutics Price to Book Value: 33.66 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 33.61 |
| November 01, 2024 | 31.98 |
| October 31, 2024 | 31.31 |
| October 30, 2024 | 31.41 |
| October 29, 2024 | 36.76 |
| October 28, 2024 | 37.45 |
| October 25, 2024 | 35.80 |
| October 24, 2024 | 32.77 |
| October 23, 2024 | 33.73 |
| October 22, 2024 | 34.66 |
| October 21, 2024 | 34.50 |
| October 18, 2024 | 35.70 |
| October 17, 2024 | 36.31 |
| October 16, 2024 | 39.49 |
| October 15, 2024 | 36.76 |
| October 14, 2024 | 34.08 |
| October 11, 2024 | 33.58 |
| October 10, 2024 | 31.32 |
| October 09, 2024 | 31.81 |
| October 08, 2024 | 33.14 |
| October 07, 2024 | 31.85 |
| October 04, 2024 | 32.13 |
| October 03, 2024 | 31.32 |
| October 02, 2024 | 32.89 |
| October 01, 2024 | 33.83 |
| Date | Value |
|---|---|
| September 30, 2024 | 36.86 |
| September 27, 2024 | 78.68 |
| September 26, 2024 | 85.93 |
| September 25, 2024 | 85.29 |
| September 24, 2024 | 90.41 |
| September 23, 2024 | 82.54 |
| September 20, 2024 | 91.88 |
| September 19, 2024 | 87.25 |
| September 18, 2024 | 92.52 |
| September 17, 2024 | 98.78 |
| September 16, 2024 | 111.06 |
| September 13, 2024 | 120.29 |
| September 12, 2024 | 103.26 |
| September 11, 2024 | 85.52 |
| September 10, 2024 | 85.31 |
| September 09, 2024 | 71.09 |
| September 06, 2024 | 45.57 |
| September 05, 2024 | 46.43 |
| September 04, 2024 | 44.57 |
| September 03, 2024 | 46.80 |
| August 30, 2024 | 48.21 |
| August 29, 2024 | 47.76 |
| August 28, 2024 | 48.73 |
| August 27, 2024 | 50.03 |
| August 26, 2024 | 49.21 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.028
Minimum
Dec 01 2022
173.39
Maximum
May 30 2024
14.37
Average
6.083
Median
Aug 16 2021
Price to Book Value Benchmarks
| Merck & Co Inc | 5.905 |
| Terns Pharmaceuticals Inc | 2.280 |
| Instil Bio Inc | 0.9005 |
| Viking Therapeutics Inc | 7.788 |
| Moderna Inc | 1.736 |
Price to Book Value Related Metrics
| PS Ratio | 14834.79 |
| Price | 19.99 |
| Earnings Yield | -1.20% |
| Market Cap | 14.74B |